![](/img/cover-not-exists.png)
Why TP53 status does not associate with clinical endpoints in ovarian cancer: Facts and hypotheses
Jolanta KupryjańczykVolume:
100
Year:
2006
Language:
english
Pages:
3
DOI:
10.1016/j.ygyno.2005.08.003
File:
PDF, 79 KB
english, 2006